Trial Profile
A Randomised Control Trial To Evaluate Whether Zoledronate Prevents Bone Loss In Acute Exacerbations Of Multiple Sclerosis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2016
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone resorption; Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- 06 Jul 2011 New trial record